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OBJECTIVE: To evaluate the effects of percutaneous coronary intervention and thrombolysis after restoration of
spontaneous circulation in cardiac arrest patients with ST-elevation myocardial infarction using meta-analysis.
METHODS: We performed a meta-analysis of clinical studies indexed in the PUBMED, MEDLINE and EMBASE
databases and published between January 1995 and October 2012. In addition, we compared the hospital
discharge and neurological recovery rates between the patients who received percutaneous coronary
intervention and those who received thrombolysis.
RESULTS: Twenty-four studies evaluating the effects of percutaneous coronary intervention or thrombolysis
after restoration of spontaneous circulation in cardiac arrest patients with ST-elevation myocardial infarction
were included. Seventeen of the 24 studies were used in this meta-analysis. All studies were used to compare
percutaneous coronary intervention and thrombolysis. The meta-analysis showed that the rate of hospital
discharge improved with both percutaneous coronary intervention (p,0.001) and thrombolysis (p,0.001). We
also found that cardiac arrest patients with ST-elevation myocardial infarction who received thrombolysis after
restoration of spontaneous circulation did not have decreased hospital discharge (p=0.543) or neurological
recovery rates (p=0.165) compared with those who received percutaneous coronary intervention.
CONCLUSION: In cardiac arrest patients with ST-elevation myocardial infarction who achieved restoration of
spontaneous circulation, both percutaneous coronary intervention and thrombolysis improved the hospital
discharge rate. Furthermore, there were no significant differences in the hospital discharge and neurological
recovery rates between the percutaneous coronary intervention-treated group and the thrombolysis-treated
group.
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& INTRODUCTION
Cardiac arrest (CA) is a major cause of death in adults
both in and out of the hospital. The percentage of patients
who survive to hospital discharge is approximately 5-10% at
best (1). Cardiopulmonary resuscitation (CPR) is essential to
prevent death and provide neuroprotection after CA.
However, the hospital discharge rates following in-hospital
CPR remain as low as they were 50 years ago, at 15-20% (2).
Epidemiological studies have shown that coronary artery
disease is the primary cause of CA, resulting in arrest within
a short time due to acute myocardial infarction (AMI) or
ischemia-related arrhythmias in 56-88% of clinical cases
with CA (3,4). Autopsy studies have demonstrated that
coronary arteries occluded by thrombi or ruptured athero-
sclerotic plaques have been identified in up to 95% of
patients who die from sudden cardiac death (SCD) (5,6).
Clinical studies have shown that reperfusion therapy
reduces the high mortality rate, particularly in patients with
ST-elevation myocardial infarction (STEMI) (7). Some
studies have demonstrated that percutaneous coronary
intervention (PCI) is beneficial in patients with STEMI (8-
10). Meanwhile, a meta-analysis also indicated that throm-
bolysis is an effective treatment for STEMI patients (11).
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However, a large-scale multicenter prospective study
(TROICA) indicated that thrombolysis is ineffective in
patients with CA after STEMI, and that study was stopped
prematurely because of the convincing early-stage data (12).
Therefore, the controversy still exists regarding the effica-
cies of PCI and thrombolysis in patients with CA after
STEMI (12-17).
Both PCI and thrombolysis are efficacious in patients
with STEMI. However, there is a significant difference
between the efficacies of PCI and thrombolysis in patients
with CA after STEMI. We assumed that most studies did
not distinguish the condition of patients with STEMI.
Thrombolysis may be used to treat patients without return
of spontaneous circulation (ROSC) after CA. Therefore, the
high mortality rate of patients with CA masked the benefit
of thrombolysis. However, PCI can be used to treat patients
with ROSC after CA. Herein, we assessed the efficacies of
PCI and thrombolysis in patients with ROSC after CA in the
presence of STEMI.
& METHODS
Study identification strategy
We searched for research papers indexed in the
PUBMED, MEDLINE and EMBASE databases that were
published from January 1995 to October 2012. The keywords
used in the search were as follows: cardiac arrest or
cardiopulmonary resuscitation or cardiopulmonary-cerebral
resuscitation and thrombolysis or percutaneous coronary
intervention and acute myocardial infarction. Furthermore,
we manually reviewed the references for each article. The
search was limited using the search terms ‘‘.19 years’’,
‘‘Publication Date from 1995/01/01 to 2012/10/01’’,
‘‘English’’, ‘‘Human’’, ‘‘PUBMED’’, ‘‘MEDLINE’’ and
‘‘EMBASE’’. We excluded research papers with the follow-
ing keywords: ‘‘review’’, ‘‘review literature’’, ‘‘review of
reported cases’’, ‘‘review, academic’’, ‘‘review, multicase’’,
‘‘review, tutorial’’, ‘‘case reports’’, ‘‘congresses’’, ‘‘inter-
view’’, ‘‘overall’’, ‘‘comment’’, ‘‘letter’’, ‘‘practice guide-
line’’, ‘‘scientific integrity review’’, ‘‘news’’, ‘‘newspaper
article’’ and ‘‘address’’. Some papers not included in the
PUBMED, MEDLINE and EMBASE databases were also
used in this meta-analysis.
Inclusion criteria
Eligible patients had experienced CA due to STEMI and
achieved ROSC after CPR. The diagnosis of CA and whether
CPR was used were determined based on the records in the
respective studies. The diagnostic and management process
that was followed was in accordance with the Utstein
model. All the included articles were non-randomized
comparative studies. Patients with ROSC after CA who
then received PCI or thrombolysis treatment constituted the
treatment groups. The types of PCI and the doses of
thrombolytic agents used were not restricted. Patients in the
control groups were those who underwent CA and achieved
ROSC and who could be treated by CPR without PCI or
thrombolysis. We compared the efficacies of PCI and
thrombolysis between the treatment and control groups.
We also compared the efficacies of PCI and thrombolysis in
patients with ROSC after CA. The primary study endpoints
were the rates of hospital discharge and neurological
recovery.
Statistical analysis
We performed a meta-analysis using Review Manager 5.1
(The Cochrane Collaboration, Oxford, England). Odds ratios
(ORs) and 95% confidence intervals (95%CIs) were calcu-
lated for each article using either the fixed-effects or the
random-effects model. We used Cochran’s x2 test and the I2
test for heterogeneity to test the between-study heterogene-
ity, and a p,0.10 and an I2.50% were considered indicative
of statistically significant heterogeneity. Between-group
comparisons were performed using Pearson’s x2 test for
categorical variables. All of the analyses were performed
using the SPSS 17.0 software package (SPSS, Inc., Chicago,
IL, USA). P-values ,0.05 were considered statistically
significant.
& RESULTS
Eligibility of articles
In total, 127 articles were found by searching using the
keywords mentioned in the methods section. Twenty-four
of these articles were cohort studies and involved CA
patients with STEMI who were treated with or without PCI
or thrombolysis after ROSC. One hundred three articles
were excluded because: they were reviews, case reports,
or letters; they reported findings for CA patients with
pulmonary embolisms (PEs) or for CA patients who had
received reperfusion therapy during CPR without ROSC; or
the authors of the study did not present the details
regarding the hospital discharge and neurological recovery
rates. Because controlled studies are necessary for meta-
analyses, the 17 cohort-controlled studies (8-10,18-31) were
included our the meta-analysis to assess the efficacies of PCI
and thrombolysis in patients with ROSC after CA. Fifteen
studies (8-10,18-29) out of the total were used to analyze the
efficacy of PCI. Four studies (26,27,30,31) were used to
analyze the efficacy of thrombolysis. After the meta-
analysis, we used all 24 studies (8-10,18-38) to compare
the hospital discharge and neurological recovery rates
between the PCI and thrombolysis groups among patients
with ROSC after CA. The main features of these selected
cohort studies are listed in Table 1.
Comparison of the hospital discharge rate between
with- and without-PCI patients with ROSC after CA
We first compared the rate of hospital discharge between
the with- and without-PCI patient groups using data from
15 articles (8-10,18-29). Overall, 1320 patients had ROSC
after CA and then received PCI treatment. A total of 860
(65.15%, 95%CI, 62.58-67.72) of these patients survived to
hospital discharge. In addition, 2152 patients with ROSC
after CA did not receive PCI, and 1017 (47.26%, 95%CI,
45.15-49.37) of these patients were discharged from the
hospital. In this meta-analysis, we used a random-effects
model to take into account the effect of heterogeneity among
studies (Tau2 = 0.33; x2 = 54.25; p,0.00001; I2 = 74%). This
meta-analysis indicated that PCI significantly improved the
rate of hospital discharge in patients with ROSC after CA
(OR, 1.92; 95% CI, 1.32-2.78, p,0.001) (Figure 1).
Comparison of neurological recovery between
with- and without-PCI patients with ROSC after CA
We also compared the neurological recovery rate between
the with- and without-PCI groups using data from 12
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articles (8-10,18-23,25,26,28). Neurological recovery was
described and recorded using the Cerebral Perfor-
mance Categories (CPC) scale. Neurological recovery was
considered good for patients who could perform their
normal activities independently (CPC 1 or 2). Neurological
recovery was considered bad, poor or unfavorable for
Table 1 - Characteristics of the studies included in the comparative analysis.
Author Study Design Type of reperfusion Participants Hospital discharge CPC 1/2
with PCI without PCI with PCI without PCI
Anyfantakis et al.* Prosp PCI 72 10/24 25/48 10/10 23/25
Cronier et al.* Retro PCI 111 29/46 31/65 29/29 25/31
Dumas et al.* Retro PCI 435 90/177 81/258 90/90 70/81
Garot et al.* Retro PCI 186 92/161 11/25 92/92 7/11
Hosmane et al.* Retro PCI 98 49/62 14/36 47/49 7/14
Kahn JK et al.* Prosp PCI 11 3/7 3/4 2/3 2/3
Koetha et al.* Retro PCI 736 114/143 248/593 103/114 208/248
Lettieri et al.* Prosp PCI 99 72/90 5/9 69/72 0/5
Merchant et al.* Prosp PCI 110 13/17 54/93
Miloslav et al.* Prosp PCI 26 13/19 2/7 11/13 2/2
N.Nielsen et al.* Retro PCI 986 197/299 358/687 180/197 254/358
T mte et al.* Prosp PCI 248 71/111 80/137 71/71 69/80
V.Gorjup et al.* Retro PCI 135 79/108 13/27
B.Bendz et al Retro PCI 40 29/40
Knafelj et al Retro PCI 72 44/72
Mager et al Retro PCI 21 18/21
Markusohn et al Retro PCI 25 19/25
Valente et al Retro PCI 31 23/31
Keelan et al Retro PCI 15 11/15
Richling et al.* Retro PCI 147 24/46 69/101 22/24 57/69
S.Bulut et al.* Retro PCI 72 4/10 23/62
Total 3676 1004/1524 1017/2152 726/764 724/927
with thrombolysis without thrombolysis
Richling et al.{ Retro thrombolysis 147 69/101 24/46 57/69 22/24
S.Bulut et al. { Retro thrombolysis 72 3/7 24/65
M.Ruiz-Baile´n et al. { Retro thrombolysis 303 55/67 127/236
W.Schreiber et al. { Retro thrombolysis 157 31/42 63/115 29/31 57/63
H.-R.Arntz et al Retro thrombolysis 50 23/50
Total 729 181/267 238/462 86/100 79/87
Retro: retrospective study; Prosp: prospective study; PCI: percutaneous coronary intervention; STEMI: ST-elevation myocardial infarction.
CPC: Cerebral Performance Categories; *Included in the meta-analysis for PCI; {Included in the meta-analysis for thrombolysis.
Figure 1 - Forest plot of the hospital discharge rates between the with- and without-PCI patients for the meta-analysis.
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patients who were dependent on others, who were
vegetative or who had died (CPC 3, 4 or 5).
The authors assessed the CPC score at the time of hospital
discharge. The rates of good neurological recovery were
95.03% (726 of 764 patients; 95%CI, 93.49-96.57) and 78.10%
(724 of 927 patients; 95%CI, 75.44-80.76) for the with- or
without-PCI patient groups, respectively. To reduce the
heterogeneity among these studies (Tau2 = 0.86; x2 = 26.40;
p= 0.006; I2 = 58%), we used a random-effects model. PCI
treatment significantly improved the rate of neurological
recovery at the time of hospital discharge in patients with
ROSC after CA (OR, 6.71; 95% CI, 2.97-15.15, p,0.001)
(Figure 2).
Comparison of the hospital discharge rate between
with- and without-thrombolysis patients with ROSC
after CA
We also compared the rate of hospital discharge between
the with- and without-thrombolysis patient groups using
data from four articles (26,27,30,31). Thrombolysis was
performed in 217 patients with ROSC after CA, and 158
(72.81%, 95%CI, 66.89-78.73) of these patients survived to
hospital discharge. In addition, 462 patients with ROSC after
CA were not treated with thrombolysis, and 238 (51.52%,
95%CI, 49.96-56.08) of these patients survived to hospital
discharge. A fixed-effects model was used in this meta-
analysis to account for the lack of heterogeneity among the
included studies (x2 = 2.87, p= 0.41, I2 = 0%), and the analysis
indicated that thrombolysis could also significantly improve
the rate of hospital discharge in patients with ROSC after
CA (OR, 2.63, 95%CI, 1.77-3.90, p,0.001) (Figure 3).
Comparison of neurological recovery between
with- and without-thrombolysis patients with
ROSC after CA
To compare the neurological recovery between the with-
and without-thrombolysis patient groups, data from two
articles were analyzed (26,31). The CPC scale was used. The
homogeneity of the two studies was good (x2 = 1.17, p= 0.28,
I2 = 15%). Therefore, we used a fix-effects model for this
meta-analysis. Overall, 86.00% (86 of 100 patients; 95% CI,
82.53-89.47) and 90.80% (79 of 87 patients; 95% CI, 84.73-
96.87) of patients had a good neurological recovery in the
patient groups with and without thrombolysis, respectively.
Thrombolysis did not improve the neurological recovery
status at the time of hospital discharge in patients with
ROSC after CA (OR, 0.76, 95%CI, 0.27-2.17, p= 0.309)
(Figure 4).
Figure 2 - Forest plot of the neurological recovery rates between the with- and without-PCI patients for the meta-analysis.
Figure 3 - Forest plot of the hospital discharge rates between the with- and without-thrombolysis patients for the meta-analysis.
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Comparison of the hospital discharge rate between
the PCI and thrombolysis groups among patients
with ROSC after CA
There were 24 articles included in this comparison of the
PCI and thrombolysis treatment groups. There were 21
articles (8-10,18-29,33-38) on PCI and 5 articles (26,27,30-32)
on thrombolysis. Among the patients included in this
analysis, 65.88% (1004 of 1524 patients, 95%CI, 63.50-68.26)
survived to hospital discharge in the PCI treatment group.
Similarly, 67.79% (181 of 267 patients, 95%CI, 62.18-73.40) of
patients in the thrombolysis treatment group survived to
hospital discharge. We found that the prognosis of patients
treated with PCI was no better than that of patients treated
with thrombolysis with respect to the hospital discharge
rates (p= 0.543, Figure 5).
Comparison of neurological recovery between the
PCI and thrombolysis groups among patients with
ROSC after CA
This comparison between the PCI and thrombolysis
groups was performed using 18 articles. There were 16
articles (8-10,18-23,25,26,28,34-37) on PCI and 3 articles
(26,31,32) on thrombolysis. Among the patients included in
this analysis, 856 patients with ROSC after CA who received
PCI survived to hospital discharge, and 790 (92.29%, 95%CI,
90.50-94.08) patients had a good neurological recovery. In
addition, 123 patients with ROSC after CA were treated
with thrombolysis and survived to hospital discharge, and
109 (88.62%, 95%CI, 83.01-94.23) patients had good neuro-
logical recovery. We noted that the PCI treatment group did
not have a significantly better neurological recovery rate
than the thrombolysis treatment group among patients with
ROSC after CA (p= 0.165, Figure 5).
Comparison of the hospital discharge and
neurological recovery rates in patients with ROSC
after in-hospital CA (IHCA) or out-of-hospital CA
(OHCA)
Even after excluding studies involving IHCA
(20,21,24,29,30,36), results similar to those described above
were obtained. Thus, PCI and thrombolysis had the same
level of efficacy in patients with ROSC whether they
experienced IHCA or OHCA.
& DISCUSSION
Based on the 17 included studies (8-10,18-31), the meta-
analysis indicated that both PCI and thrombolysis could
improve the hospital discharge rate for patients with ROSC
after CA, but only PCI could improve the neurological
recovery rate. However, further analysis using a total of 24
studies (8-10,18-38) indicated that there were not significant
differences in the hospital discharge and neurological
recovery rates between the PCI and thrombolysis treatment
groups.
PCI and thrombolysis are the two main reperfusion
strategies currently in use. According to the recent AHA
guidelines concerning CPR for ACS (acute coronary
syndrome) patients (39), PCI may be considered for patients
with ROSC after CA. Our data indicate that such a strategy
improved the rate of hospital discharge and enhanced
neurological recovery in patients with ROSC following CA.
However, the efficacy of thrombolysis has been rarely
mentioned in regard to CA patients. A recent randomized
study (TROICA) reported that thrombolysis did not
improve the hospital discharge and neurological recovery
rates in patients with CA. The TROICA researchers reported
that one possible reason might be the administration of
antithrombin and antiplatelet agents during CPR. Another
important reason might be the restriction of the perfusion of
vital organs during CPR by blood clots in the coronary
arteries, limiting the perfusion pressure and hindering the
delivery of the thrombolytic agents to the location where
they were to play their thrombolytic role (12). We concluded
that one main possible reason for the lack of efficacy for
thrombolysis might have been the lack of distinguishing
patients with ROSC after CA from those without ROSC;
when CA patients achieve ROSC, there may be suitable
perfusion pressure in the coronary arteries, allowing
Figure 4 - Forest plot of the neurological recovery rates between the with- and without-thrombolysis patients for the meta-analysis.
Figure 5 - Comparison of the hospital discharge and neurological
recovery rates between the PCI and thrombolysis groups Left:
Comparison of the hospital discharge rates between the PCI and
thrombolysis groups (p = 0.543) Right: Comparison of the
neurological recovery rates between the PCI and thrombolysis
groups (p=0.165).
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thrombolysis could function effectively. In this study, we
studied the efficacies of thrombolysis and PCI in patients
with ROSC after CA, and we identified no differences in the
hospital discharge and neurological recovery rates.
Plaque rupture, thrombus collapse and embolisms play
key roles in the pathogenesis of SCD (5,6). Clinical studies
have already identified disrupted atherosclerotic plaques or
occlusive thrombi in CA survivors using coronary angio-
graphy (4). Therefore, early reperfusion therapy in patients
with STEMI is an important cornerstone of the recom-
mended therapy and is also recommended by the European
Society of Cardiology (ESC) (40). Reperfusion treatment has
been used to treat AMI patients for the past 20 years. As the
two main reperfusion approaches for AMI, PCI and
thrombolysis can recanalize the occluded artery, reduce
the infarct size, minimize myocardial damage, enhanced left
ventricular recovery, reduce the incidence of arrhythmias
and decrease mortality (13). Because AMI is the main
underlying cause of CA (3,4), therapeutic strategies for
coronary reperfusion should be equally appropriate for CA
patients. However, in clinical practice, there is still some
controversy concerning the roles and efficacies of PCI and
thrombolysis for the treatment of patients with CA caused
by AMI (4,12,17,20,22).
PCI can directly open the occluded coronary artery and
stabilize hemodynamics. Many clinical studies on reperfu-
sion therapy have indicated that immediate PCI after CA is
a safe procedure and is associated with a good prognosis
(4,8,20,22,27,29,33,37). A series of large-scale clinical studies
demonstrated that PCI has pronounced efficacy for treating
CA patients with STEMI (8-10), a result that was confirmed
by our meta-analysis. We know that thrombolysis is able to
improve the prognosis of STEMI patients and has an
efficacy comparable to that of PCI. However, it is not clear
why there is such a large difference between these
treatments in CA patients. After carefully analyzing the
relevant articles (4,12,17,20,22), we found that this difference
may be the result of the selection of the study populations.
PCI was used to treat patients with STEMI without CA. In
contrast, thrombolysis was most often used to treat patients
with STEMI with CA because of its convenience and rapid
action. The high mortality rate of CA patients masked the
benefit of thrombolysis for the treatment of AMI (41-43).
With the development of CPR, medical scientists have
realized the importance of neuroprotection after CPR,
especially in patients with ROSC after CA. Our meta-
analysis and comparative analysis aimed to evaluate the
benefits of PCI and thrombolysis for patients with ROSC
after CA.
In this study, we found that both PCI and thrombolysis
improved the hospital discharge rates of patients with
ROSC after CA. There were no significant differences in the
hospital discharge and neurological recovery rates of CA
patients. We also found that thrombolysis could improve
the hospital discharge rate, but it could not improve the
neurological recovery rate. However, several studies have
demonstrated that thrombolysis also results in good
neurological recovery in CA patients. Hemodynamic stu-
dies indicate that thrombolysis can decrease microthrom-
bosis, improve microcirculation metabolism and further
promote neurological recovery (30,31). Therefore, we con-
cluded that the previous studies are insufficient to de-
monstrate the benefit of thrombolysis in neurological
recovery.
Reperfusion therapy can open the occluded artery and
rescue dying myocardium in patients with ROSC after CA.
PCI is used to treat patients with STEMI but without CA,
preventing many deaths. Thrombolysis is used to treat
patients with STEMI during CPR. However, patient
hemodynamics are unstable during that time. This instabil-
ity may be the reason why the results were so dismal. Our
results indicate that the first step should be the selection of
patients with ROSC after CA; then, the decision between
PCI and thrombolysis can be made. In developing countries,
the mortality rate for ischemic heart disease is expected to
increase by almost 120-137%, compared with 29-48% in
developed countries, between 1990 and 2020; however,
developing countries cannot afford the widely used
expensive PCI techniques (44,45). Compared with PCI,
thrombolysis is convenient and rapid, has a similar efficacy
and is relatively simple, making it especially suited for use
in clinics that cannot perform PCI. Our findings provide
information to guide the resuscitation of patients with
ROSC after CA. Of course, these results require validation
by additional randomized control trials.
In conclusion, our comparative analysis demonstrated
that thrombolysis had an efficacy similar to that of PCI in
patients with ROSC after CA. Our results indicate that there
is still a need to conduct large-scale randomized clinical
trials to confirm the benefits of thrombolysis in patients with
ROSC after CA and in the presence of STEMI.
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